Oncoclínicas do Brasil Serviços Médicos S.A.

BOVESPA:ONCO3 Lagerbericht

Marktkapitalisierung: R$3.1b

Oncoclínicas do Brasil Serviços Médicos Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Oncoclínicas do Brasil Serviços Médicos wird ein jährliches Gewinn- und Umsatzwachstum von 38.8% bzw. 12.2% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 26.6% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 16.1% betragen.

Wichtige Informationen

33.6%

Wachstumsrate der Gewinne

32.4%

EPS-Wachstumsrate

Healthcare Gewinnwachstum27.8%
Wachstumsrate der Einnahmen12.0%
Zukünftige Eigenkapitalrendite9.5%
Analystenabdeckung

Good

Zuletzt aktualisiert18 Sep 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Here's What Analysts Are Forecasting For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) After Its Second-Quarter Results

Aug 15
Here's What Analysts Are Forecasting For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) After Its Second-Quarter Results

Recent updates

With A 25% Price Drop For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) You'll Still Get What You Pay For

Sep 27
With A 25% Price Drop For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) You'll Still Get What You Pay For

Here's What Analysts Are Forecasting For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) After Its Second-Quarter Results

Aug 15
Here's What Analysts Are Forecasting For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) After Its Second-Quarter Results

Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) Takes On Some Risk With Its Use Of Debt

Aug 13
Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) Takes On Some Risk With Its Use Of Debt

Earnings Tell The Story For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) As Its Stock Soars 27%

Jul 16
Earnings Tell The Story For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) As Its Stock Soars 27%

Is Now An Opportune Moment To Examine Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)?

Jul 03
Is Now An Opportune Moment To Examine Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)?

Investors Appear Satisfied With Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Prospects As Shares Rocket 25%

Jun 01
Investors Appear Satisfied With Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Prospects As Shares Rocket 25%

Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Share Price Is Still Matching Investor Opinion Despite 27% Slump

Apr 17
Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Share Price Is Still Matching Investor Opinion Despite 27% Slump

Oncoclínicas do Brasil Serviços Médicos' (BVMF:ONCO3) Earnings Are Weaker Than They Seem

Apr 03
Oncoclínicas do Brasil Serviços Médicos' (BVMF:ONCO3) Earnings Are Weaker Than They Seem

Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) Has A Somewhat Strained Balance Sheet

Mar 11
Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) Has A Somewhat Strained Balance Sheet

What Does Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Share Price Indicate?

Feb 17
What Does Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Share Price Indicate?

It's A Story Of Risk Vs Reward With Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)

Dec 08
It's A Story Of Risk Vs Reward With Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)

Why Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Could Be Worth Watching

Nov 06
Why Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Could Be Worth Watching

Is Now The Time To Put Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) On Your Watchlist?

Sep 11
Is Now The Time To Put Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) On Your Watchlist?

Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Just Reported Earnings, And Analysts Cut Their Target Price

Apr 03
Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Just Reported Earnings, And Analysts Cut Their Target Price

Gewinn- und Umsatzwachstumsprognosen

BOVESPA:ONCO3 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (BRL Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20268,261531359N/A7
12/31/20257,428420291N/A9
12/31/20246,449198-553N/A9
6/30/20245,862193-614-310N/A
3/31/20245,654211-25662N/A
12/31/20235,489224-363-52N/A
9/30/20235,271219-33285N/A
6/30/20235,033145-24978N/A
3/31/20234,57491-642-346N/A
12/31/20224,08846-572-272N/A
9/30/20223,640-10-740-378N/A
6/30/20223,155105-593-324N/A
3/31/20222,895-67-415-185N/A
12/31/20212,702-47-211-9N/A
9/30/20212,509-203-13827N/A
6/30/20212,354-334-1289N/A
3/31/20212,182-145-17154N/A
12/31/20202,035-158-19186N/A
12/31/20191,690-20-9397N/A
12/31/20181,051-17-296-18N/A
12/31/20177923N/A135N/A
12/31/2016595-25N/A-21N/A
12/31/2015458-25N/A-3N/A
12/31/2014359-22N/A9N/A
12/31/201326921N/A7N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: ONCO3Das prognostizierte Gewinnwachstum (38.8% pro Jahr) liegt über der Sparquote (9.9%).

Ertrag vs. Markt: ONCO3Die Erträge des Unternehmens (38.8% pro Jahr) werden voraussichtlich schneller wachsen als der Markt BR (14% pro Jahr).

Hohe Wachstumserträge: ONCO3Es wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: ONCO3Die Einnahmen des Unternehmens (12.2% pro Jahr) werden voraussichtlich schneller wachsen als der Markt BR (7.2% pro Jahr).

Hohe Wachstumseinnahmen: ONCO3Die Einnahmen des Unternehmens (12.2% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: ONCO3Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (16.1%).

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y